These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16538473)

  • 1. Geographical distribution and disease associations of the CD45 exon 6 138G variant.
    Ward V; Hennig BJ; Hirai K; Tahara H; Tamori A; Dawes R; Saito M; Bangham C; Stephens H; Goldfeld AE; Kunachiwa W; Leetrakool N; Hopkin J; Dunstan S; Hill A; Bodmer W; Beverley PC; Tchilian EZ
    Immunogenetics; 2006 Apr; 58(2-3):235-9. PubMed ID: 16538473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease associations and altered immune function in CD45 138G variant carriers.
    Boxall S; Stanton T; Hirai K; Ward V; Yasui T; Tahara H; Tamori A; Nishiguchi S; Shiomi S; Ishiko O; Inaba M; Nishizawa Y; Dawes R; Bodmer W; Beverley PC; Tchilian EZ
    Hum Mol Genet; 2004 Oct; 13(20):2377-84. PubMed ID: 15333587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPRC (CD45) variation and disease association studied using single nucleotide polymorphism tagging.
    Hennig BJ; Fry AE; Hirai K; Tahara H; Tamori A; Moller M; Hopkin J; Hill AV; Bodmer W; Beverley P; Tchilian E
    Tissue Antigens; 2008 May; 71(5):458-63. PubMed ID: 18312479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD45 exon 4 point mutation does not confer susceptibility to type 1 diabetes mellitus or Graves' disease.
    Wood JP; Bieda K; Segni M; Herwig J; Krause M; Usadel KH; Badenhoop K
    Eur J Immunogenet; 2002 Feb; 29(1):73-4. PubMed ID: 11841494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-frequency polymorphism in exon 6 of the CD45 tyrosine phosphatase gene (PTPRC) resulting in altered isoform expression.
    Stanton T; Boxall S; Hirai K; Dawes R; Tonks S; Yasui T; Kanaoka Y; Yuldasheva N; Ishiko O; Bodmer W; Beverley PC; Tchilian EZ
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5997-6002. PubMed ID: 12716971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans.
    Zilch CF; Walker AM; Timón M; Goff LK; Wallace DL; Beverley PC
    Eur J Immunol; 1998 Jan; 28(1):22-9. PubMed ID: 9485182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
    Lemaire R; Winne A; Sarkissian M; Lafyatis R
    Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CD45 polymorphism associated with abnormal splicing is absent in African populations.
    Tchilian EZ; Dawes R; Ramaley PA; Whitworth JA; Yuldasheva N; Wells RS; Watera C; French N; Gilks CF; Kunachiwa W; Ruzibakiev R; Leetrakool N; Carrington CV; Ramdath DD; Gotch F; Stephens HA; Hill AV; Beverley PC
    Immunogenetics; 2002 Feb; 53(10-11):980-3. PubMed ID: 11862398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection.
    Dawes R; Hennig B; Irving W; Petrova S; Boxall S; Ward V; Wallace D; Macallan DC; Thursz M; Hill A; Bodmer W; Beverley PC; Tchilian EZ
    J Med Genet; 2006 Aug; 43(8):678-84. PubMed ID: 16505159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer.
    Lynch KW; Weiss A
    J Biol Chem; 2001 Jun; 276(26):24341-7. PubMed ID: 11306584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A C77G point mutation in CD45 exon 4, which is associated with the development of multiple sclerosis and increased susceptibility to HIV-1 infection, is undetectable in Japanese population.
    Sabouri AH; Saito M; Matsumoto W; Kodama D; Farid R; Izumo S; Usuku K; Osame M
    Eur J Neurol; 2003 Nov; 10(6):737-9. PubMed ID: 14641523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans.
    Tchilian EZ; Wallace DL; Imami N; Liao HX; Burton C; Gotch F; Martinson J; Haynes BF; Beverley PC
    J Immunol; 2001 May; 166(10):6144-8. PubMed ID: 11342634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis.
    Boxall S; McCormick J; Beverley P; Strobel S; De Filippi P; Dawes R; Klersy C; Clementi R; De Juli E; Ferster A; Wallace D; Aricò M; Danesino C; Tchilian E
    Pediatr Res; 2004 Mar; 55(3):478-84. PubMed ID: 14630980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of C77G polymorphism in exon 4 of the CD45 gene in the Spanish population].
    Gil J; Ruiz-Tíscar JL; Rodríguez-Sainz C; Hernández A; Santamaría B; García-Sánchez F; Fernández-Cruz E
    Med Clin (Barc); 2005 Jun; 125(1):10-1. PubMed ID: 15960938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of amino acids at the junction of exons 3 and 7 that are used for the generation of glycosylation-related human CD45RO and CD45RO-like antigen specificities.
    Pulido R; Schlossman SF; Saito H; Streuli M
    J Exp Med; 1994 Mar; 179(3):1035-40. PubMed ID: 7509359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel CD45 transcript involving the alternative splicing of a new exon is widely distributed in lymphoid tissues.
    Li D; Brackenridge S; Screaton GR
    Hum Immunol; 2004 Dec; 65(12):1539-45. PubMed ID: 15603882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD45 variant alleles: possibly increased frequency of a novel exon 4 CD45 polymorphism in HIV seropositive Ugandans.
    Stanton T; Boxall S; Bennett A; Kaleebu P; Watera C; Whitworth J; French N; Dawes R; Hill AV; Bodmer W; Beverley PC; Tchilian EZ
    Immunogenetics; 2004 May; 56(2):107-10. PubMed ID: 15057492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers.
    Gomez-Lira M; Liguori M; Magnani C; Bonamini D; Salviati A; Leone M; Andreoli V; Trojano M; Valentino P; Savettieri G; Quattrone A; Pignatti PF; Momigliano-Richiardi P; Giordano M
    J Neuroimmunol; 2003 Jul; 140(1-2):216-21. PubMed ID: 12864992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A disease-associated polymorphism alters splicing of the human CD45 phosphatase gene by disrupting combinatorial repression by heterogeneous nuclear ribonucleoproteins (hnRNPs).
    Motta-Mena LB; Smith SA; Mallory MJ; Jackson J; Wang J; Lynch KW
    J Biol Chem; 2011 Jun; 286(22):20043-53. PubMed ID: 21507955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing.
    Preussner M; Schreiner S; Hung LH; Porstner M; Jäck HM; Benes V; Rätsch G; Bindereif A
    Nucleic Acids Res; 2012 Jul; 40(12):5666-78. PubMed ID: 22402488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.